In some aspects, polypeptides comprising single domain antibodies and methods of identifying single domain antibodies are provided.
Single domain antibodies against SOD1and their use in medicine Abstract The present application relates to the field of single domain antibodies (also called nanobodies), more particularly single domain antibodies against SOD1 protein isoforms.
The substrate comprises a dialectric layer having a single phase, single domain crystalline stracture.
The present invention is directed to a synthetic apolipoprotein-E mimicking polypeptide consisting of a single domain.
The present disclosure also provides various improvements relating to single domain binding polypeptides.
Each isolated domain is assigned a unique domain identifier.
There is provided a single-chain fusion protein comprising:(i)a thermostable kinase and(ii)a single-domain antibody or single-domain antibody fragment.
Antibodies (e.g., sdAbs) binding to PCSK9 are described.
The invention secures a unique domain name and corresponding web site with subdomain web pages for the item.
The present invention relates to single domain proteins that bind to epidermal growth factor receptor (EGFR).
Such single domain particle have a diameter in the range of about 5 nm to 80 nm.
Nodes merged into supernodes are maintained in a single subdomain during partitioning.
The invention also relates to single domain proteins for use in diagnostic, research and therapeutic applications.
The present invention utilizes a CDR3 area of a single domain antibody to display an exogenous epitope.
SDl and SD2 are the first human single-domain antibodies targeting mesothelin-expressing tumors.
A server having a unique domain name and the same IP address is allocated for each of the domains, while a software module intermediates between a client of the service and each of the servers.